Predict your next investment

US Department of Veterans Affairs company logo
INTERNET | Internet Software & Services / HR & Workforce Management
vacareers.va.gov

See what CB Insights has to offer

Founded Year

1989

About US Department of Veterans Affairs

US Department of Veterans Affairs offers an online platform for job seekers to browse opportunities to work in the Veterans Health Administration. There are opportunities for physicians, nurses, mental health professionals, and more.

US Department of Veterans Affairs Headquarter Location

810 Vermont Avenue

Washington, DC, 20420,

United States

844-456-5208

Latest US Department of Veterans Affairs News

Destiny Pharma unveils positive results for c-difficile treatment as research points to commercial potential

Jan 24, 2022

Destiny Pharma unveils positive results for c-difficile treatment as research points to commercial potential NTCD-M3, which researchers are readying to phase III clinical trials, was the subject to a separate preclinical study by the US Department of Veterans Affairs Destiny Pharma PLC (AIM:DEST) hailed the ‘significant commercial opportunity’ of its c-difficile treatment as it unveiled positive results of a study carried out by the US Department of Veterans Affairs. NTCD-M3, which researchers are readying to phase III clinical trials, was the subject of a separate preclinical study to assess its ability to colonise the gut after antibiotics are given. The results revealed the drug was 100% effective in doing so following the administration of two front-line treatments - vancomycin and fidaxomicin. Oral antibiotics such as the two mentioned above kill beneficial bacteria in the gut, causing unintentional and harmful collateral damage. Specifically, this harm allows CDI (NYSE:CDI) to grow in the gut to release toxins. “We are encouraged by these latest findings that support the administration of NTCD-M3 to the broadest CDI (NYSE:CDI) patient population receiving any approved antibiotic treatment and strengthens our planning for the NTCD-M3 phase III study, which we aim to start later this year,” said chief executive Neil Clark. In the same announcement, investors were told North American and European market research had shown there is significant interest in NTCD-M3 as a product, while doctors are optimistic about its potential. “The market research further supports these findings and will be invaluable in helping to position NTCD-M3 for the prevention of CDI (NYSE:CDI) , as well as development and commercial considerations critical to determining the product's market potential,” said CEO Clark. “There is significant value potential in our NTCD-M3 asset, and we look forward to providing further updates on the regulatory and development plans throughout 2022." Quick facts: Destiny Pharma PLC Follow

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing US Department of Veterans Affairs

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned US Department of Veterans Affairs in 1 CB Insights research brief, most recently on Sep 13, 2021.

Expert Collections containing US Department of Veterans Affairs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

US Department of Veterans Affairs is included in 1 Expert Collection, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

US Department of Veterans Affairs Patents

US Department of Veterans Affairs has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/28/2015

3/30/2021

Transcription factors, Clusters of differentiation, Oncology, Monoclonal antibodies, Cell biology

Grant

Application Date

8/28/2015

Grant Date

3/30/2021

Title

Related Topics

Transcription factors, Clusters of differentiation, Oncology, Monoclonal antibodies, Cell biology

Status

Grant

US Department of Veterans Affairs Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

US Department of Veterans Affairs Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.